| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/27/2005 | EP1325010B1 Substituted 3.4-dihydro-pyrimido [1,2-a]pyrimidines and 3.4-dihydropyrazino [1,2-a]pyrimidines |
| 04/27/2005 | EP1286668B1 Pharmaceutical combinations comprising tegaserod und omeprazole and their use in treating gastrointestinal disorders |
| 04/27/2005 | EP0906307B1 Substituted imidazoles having cytokine inhibitory activity |
| 04/27/2005 | EP0838453B1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 04/27/2005 | CN1610751A Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof |
| 04/27/2005 | CN1610748A Recombinant MVA capable of expressing structural HCV antigens |
| 04/27/2005 | CN1610693A Transdifferentiation of pancreatic acinar cells |
| 04/27/2005 | CN1610684A Novel multi-ring organic compounds for regulating gut motility and food intake |
| 04/27/2005 | CN1610674A Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase |
| 04/27/2005 | CN1610671A Quinoline compounds with 5-HT-antagonistic properties for therapy |
| 04/27/2005 | CN1610670A 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 04/27/2005 | CN1610669A Heteroaryl-substituted aminocyclohexane derivatives |
| 04/27/2005 | CN1610668A Substituted propane-1, 3-diamine derivatives and the pharmaceutical use |
| 04/27/2005 | CN1610667A 3-nitropyridine derivaives and the pharmaceutical compositions containing said derivatives |
| 04/27/2005 | CN1610664A 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists |
| 04/27/2005 | CN1610661A Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 04/27/2005 | CN1610554A Chinese herbal medicine composition with treating heatstroke purpose and preparing method thereof |
| 04/27/2005 | CN1610553A Nucleic acid-based compounds and methods of use thereof |
| 04/27/2005 | CN1610544A Method for preventing and treating visceral pain and gastrointestinal disorders |
| 04/27/2005 | CN1610542A New use for the treatment of gastroesophageal reflux disease |
| 04/27/2005 | CN1609123A Variable region sequence of hepatitis B virus monoclonal antibody, gene engineering antibody containing the variable region and its use |
| 04/27/2005 | CN1608676A Orally taken carrier to transduce liver and intestine cell |
| 04/27/2005 | CN1608665A Blattbulume extract and its prepn process and application |
| 04/27/2005 | CN1608658A Hepatitis treating Chinese medicine prepn and its production process |
| 04/27/2005 | CN1608653A Tranquilizing medicine powder for treating hepatic coma |
| 04/27/2005 | CN1608646A Wolfberry fruit-astragalus root oral liquid and its prepn process |
| 04/27/2005 | CN1608645A Medicine for promoting gastrointestinal function and its prepn process |
| 04/27/2005 | CN1608641A Food composition with stomach nourishing and protecting function and its prepn process |
| 04/27/2005 | CN1608638A Blood cleaning metabolism bolus |
| 04/27/2005 | CN1608620A Solid bicyclic alcohol dispersion |
| 04/27/2005 | CN1608615A Fibrauretine-amino acid fluid for transfusion and its production process |
| 04/27/2005 | CN1608613A Fibrauretine powder for injection and its production process |
| 04/27/2005 | CN1608513A Health food containing hyaluronic acid and dermatan sulfate |
| 04/27/2005 | CN1198832C New amino propylphosphinic acid |
| 04/27/2005 | CN1198825C 8-pheyl-6,9-dihydro-[1,2,4]triazolo[3,4-i] purin-5-one derivatives |
| 04/27/2005 | CN1198818C Compound with growth hormone releasing properties |
| 04/27/2005 | CN1198814C Salt |
| 04/27/2005 | CN1198653C Preparations for preventing bile acid diarrhea |
| 04/27/2005 | CN1198638C Gallstone capsule |
| 04/27/2005 | CN1198637C Health cosmetic composition |
| 04/27/2005 | CN1198636C Application of dandelion herb in preparing medicines |
| 04/27/2005 | CN1198631C Use of bifidobacteria in preparing medicine for preventing diarrhea |
| 04/27/2005 | CN1198630C Preparation containing dragonfly and male silkworm moth |
| 04/27/2005 | CN1198628C Conditioned cell culture medium compositions and method of use |
| 04/27/2005 | CN1198626C Method and system for production and collection of lavage induced stool (LIS) for chemical and biologic tests of cells |
| 04/27/2005 | CN1198625C Pharmaceutical compositions for treatment of mucositis, stomatitis and Behchet's syndrome |
| 04/27/2005 | CN1198624C Oligosaccharide mixture |
| 04/27/2005 | CN1198618C Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |
| 04/27/2005 | CN1198594C Therapeutically active compositions |
| 04/27/2005 | CN1198592C Process for producing particles with converted amorphous and/or meta-stable drystalline region into crystalline state |
| 04/26/2005 | US6884810 Benzimidazole derivatives |
| 04/26/2005 | US6884808 Acids and salts such as 4-(4-(2-(2-(5,6,7,8-Tetrahydro-5,5,8, 8-tetramethylquinoxalyl))pyrrolyl))benzoic acid, used retinoic acid receptor agonists for the prophylaxis of cancer, skin disorders, asthma, alopecia or autoimmune diseases |
| 04/26/2005 | US6884807 3-bicyclic carbocyclic group substituted quinuclidine derivatives, which are cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptor and transporters |
| 04/26/2005 | US6884804 Inhibitors of Src and other protein kinases |
| 04/26/2005 | US6884803 Phenylalkynes |
| 04/26/2005 | US6884802 Phenanthridines substituted in position 6 by a mono, bi- or tricyclic heteroaryl radical; cyclic nucleotidephosphoesterase (PDE4) inhibitor and useful for treating respiratory system disorders |
| 04/26/2005 | US6884801 Nitrogen compounds such as N-(4,5-dihydro-1H-imidazol-2-yl-methyl)-2-(methylsulfonyl)aniline, used for prophylaxis of incontinence |
| 04/26/2005 | US6884800 Nitrogen compounds such as 10-Chloro-3-imidazol-1-yl-2,3-dihydro-1H-pyrido(3,2,1-kl)phenothiazine, used for prophylaxis of respiratory system and skin disorders, autoimune diseases, tumors or atherosclerosis and AIDS |
| 04/26/2005 | US6884785 Compositions and methods for the treatment or prevention of autoimmune diabetes |
| 04/26/2005 | US6884768 Using taurine compound; adjust bioavailability; prevent, suppression damage to intestine mucous membrane |
| 04/26/2005 | US6884437 Administration form comprising an acid-labile active compound |
| 04/26/2005 | US6884239 Ingestible device for the release of substances at distinct locations in alimentary canal |
| 04/21/2005 | WO2005035536A1 Novel xanthone derivative, process for producing the same and pharmaceutical composition containing the same |
| 04/21/2005 | WO2005035534A1 Heterocyclic bicyclo ring and heterocyclic tricyclo ring compounds and drugs comprising the same |
| 04/21/2005 | WO2005035503A1 Novel isoquinoline derivative |
| 04/21/2005 | WO2005035471A1 Ether derivative |
| 04/21/2005 | WO2005034951A1 Methods and compositions for the oral administration of prodrugs of proton pump inhibitors |
| 04/21/2005 | WO2005034946A1 Nonsedating α-2 agonist 1- (2, 3-dimethyl-phenyl) -ethyl-1, 3-dihydro-imizadole-2-thione |
| 04/21/2005 | WO2005023741A3 Pharmaceutical compositions containing (+) cannabidiol and derivatives thereof and some such novel derivatives |
| 04/21/2005 | WO2005000405A3 P38 kinase inhibitor compositions and methods of use |
| 04/21/2005 | WO2004078169A8 Use of ep2 selective receptor agonists in medical treatment |
| 04/21/2005 | WO2004005313A3 Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules |
| 04/21/2005 | WO2003061584A3 Novel substituted benzimidazole dosage forms and method of using same |
| 04/21/2005 | WO2002098348A3 Glp-1 formulations with protracted time action |
| 04/21/2005 | WO2002092841A3 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon |
| 04/21/2005 | WO2002057425A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 04/21/2005 | US20050085758 Dilute aqueous solution containing epidermal growth factor in gel |
| 04/21/2005 | US20050085667 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 04/21/2005 | US20050085639 Circulation disorders; antiproliferative agents; hypotensive agents; cardiovascular disorders; antiischemic agents; kidney disorders; atherosclerosis; restenosis; antiinflammatory agents; respiratory system disorders; angiogenesis inhibitors; anticancer agents; antiulcer agents |
| 04/21/2005 | US20050085543 Genetic engineering; wound healing agents |
| 04/21/2005 | US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 04/21/2005 | US20050085532 Prevention, therapy of central nervous system disorders ; antidepressants; anxiolytic agents; eating and sleep disorders; Alzheimer's disease; strokes; schizophrenia; incontinence; gastrointestinal disorders; cardiovascular disorders |
| 04/21/2005 | US20050085519 Controlling cell differentiation, cell proliferation; anticancer agents |
| 04/21/2005 | US20050085514 Psychological disorders; schizophrenia; anxiolytic agents; antidepressants; bipolar diseases; circadian rhythm disorders; analgesics; Parkinson's disease; Huntington's disease |
| 04/21/2005 | US20050085510 Drug for gastrointestinal disorders |
| 04/21/2005 | US20050085509 KInase inhibitors; antiarthritic agents; autoimmune diseases; sepsis; cachexia; Alzheimer's disease; antihistamines; thrombosis; glomerulonephritis; inflammatory bowel disorders; crohn's disese; multiple sclerosis; antitumor agents; skin disorders |
| 04/21/2005 | US20050085508 Gastrointestinal disorders; antiemetic agents; irritable bowel disorders; antipruritic agents |
| 04/21/2005 | US20050085487 Heterocyclic compounds |
| 04/21/2005 | US20050085480 Water-soluble phenylpyridazine compounds and compositions containing the same |
| 04/21/2005 | US20050085469 Fused bicyclic pyrimidine derivatives |
| 04/21/2005 | US20050085461 Benzenesulfonamide derivatives |
| 04/21/2005 | US20050085457 Therapeutic quinolone compounds with 5-ht-antagonistic properties |
| 04/21/2005 | US20050085456 Compounds useful in therapy |
| 04/21/2005 | US20050085414 Novel medical use for tachykinin antagonists |
| 04/21/2005 | US20050084964 Progenitor cells which can be differentiated into hepatic, pancreatic and/or salivary gland tissues; tissue engineering and regenerative medicine |
| 04/21/2005 | US20050084897 DNA encoding human vanilloid receptor VR3 |
| 04/21/2005 | US20050084518 For producing beautiful skin and improving constipation, reducing hair loss |
| 04/21/2005 | US20050084505 Utilization of ubiquinones for influencing the effect of histamine |
| 04/21/2005 | US20050084489 Synergistic administration of Vitaxin, a FAB fragment, or a competitive binding antibody for binding integrin alpha V beta 3 with the enzyme inhibitor; antiinflammatory, anticarcinogenic agents; autoimmune and metabolic bone disorders |
| 04/21/2005 | US20050084486 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |